Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec 25;23(1):47.
doi: 10.3390/molecules23010047.

Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights

Affiliations
Review

Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights

María Vallet-Regí et al. Molecules. .

Abstract

This manuscript reviews the recent progress on mesoporous silica nanoparticles as drug delivery systems. Their intrinsic structural, textural and chemical features permit to design versatile multifunctional nanosystems with the capability to target the diseased tissue and release the cargo on demand upon exposition to internal or external stimuli. The degradation rate of these nanocarriers in diverse physiological fluids is overviewed obeying their significance for their potential translation towards clinical applications. To conclude, the balance between the benefits and downsides of this revolutionary nanotechnological tool is also discussed.

Keywords: benefits and downsides; biosafety; clinical translation; in vitro degradation; mesoporous silica nanoparticles; multifunctional nanosystem; selective targeting; stimuli-responsive drug delivery.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Number of publications per year indexed in the ISI Web of Science on the topic of “mesoporous” and “silica” and “drug” and “delivery” up to 1st November 2017.
Figure 2
Figure 2
(Left) Schematic depiction of active targeting possibilities on MSNs; (Right) Dual targeting strategy to target both cell membrane of tumor cells and mitochondria by asymmetrically functionalized nanoparticles (J-MSNs).
Figure 3
Figure 3
Schematic representation of internal or external stimuli-responsive drug delivery from MSNs.
Figure 4
Figure 4
Schematic illustration of representative internal stimuli-responsive drug delivery MSNs: pH-responsive nanosystem based on polymer coated-MSNs; redox potential-responsive based on MSNs functionalized with disulfide bonds and capped with inorganic nanoparticles; and enzyme-responsive based on MSNs coated with a degradable polymer, from left to right.
Figure 5
Figure 5
Schematic depiction of three representative external stimuli-responsive drug delivery from MSNs via alternating magnetic fields (AM Field), ultrasounds (US) and visible (Vis) light (from left to right).
Figure 6
Figure 6
Representative illustration showing the in vitro degradation process in PBS for MSNs. TEM images before and after 8 and 12 days of in vitro assay are shown. The cartoons display the degradation process at the meso and atomic scales.
Figure 7
Figure 7
Main factors that drive the degradation of MSNs in physiological environment. TEM images of MSNs before and after being soaked in PBS under physiological conditions reveal the permanence of the structural and morphological characteristics after 8 days of in vitro test.

References

    1. Vallet-Regí M., Balas F., Arcos D. Mesoporous materials for drug delivery. Angew. Chem. Int. Ed. 2007;46:7548–7558. doi: 10.1002/anie.200604488. - DOI - PubMed
    1. Fernandez-Fernandez A., Manchanda R., McGoron A. Theranostic applications of nanomaterials in cancer: Drug delivery, image-guided therapy, and multifunctional platforms. Appl. Biochem. Biotechnol. 2011;165:1628–1651. doi: 10.1007/s12010-011-9383-z. - DOI - PMC - PubMed
    1. Rosenholm J.M., Sahlgren C., Linden M. Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment. Curr. Drug Targets. 2011;12:1166–1186. doi: 10.2174/138945011795906624. - DOI - PubMed
    1. Baeza A., Colilla M., Vallet-Regí M. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery. Expert Opin. Drug Deliv. 2015;12:319–337. doi: 10.1517/17425247.2014.953051. - DOI - PubMed
    1. Argyo C., Weiss V., Braeuchle C., Bein T. Multifunctional mesoporous silica nanoparticles as a universal platform for drug delivery. Chem. Mater. 2014;26:435–451. doi: 10.1021/cm402592t. - DOI

Substances